Y-NM600

· University of Wisconsin–Madison

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Y-NM600, covering 2026-03-12 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer [Phase 1]